# High Dose Oxytocin Nasal Spray for Treatment of Tinnitus

> **NCT04210310** · PHASE3 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 33 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT04210310
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-15
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-05-10
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** PI departure from the institution.
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210310, "High Dose Oxytocin Nasal Spray for Treatment of Tinnitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04210310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*